The impact and cost-effectiveness of pneumococcal immunisation strategies for the elderly in England

The impact and cost-effectiveness of pneumococcal immunisation strategies for the elderly in England

Pneumococcal disease, presenting as invasive pneumococcal disease (IPD) or community-acquired pneumonia (CAP) is an important cause of illness and hospitalisation in the elderly. To reduce pneumococcal burden, since 2003, 65-year-olds in England have been offered a 23-valent pneumococcal polysacchar...

Descripció completa

Dades bibliogràfiques
Autors principals:	Danelian, G, Burton, L, Bayley, T, Sanchez-Marroquin, A, Park, J, Manley, H, Choi, Y, Andrews, N, Ladhani, S, Earnshaw, A, Gritzfeld, JF, Trotter, C, Panovska-Griffiths, J
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2024

Ítems similars

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
per: Shamez N. Ladhani, et al.
Publicat: (2013-01-01)

Combining models to generate a consensus effective reproduction number R for the COVID-19 epidemic status in England
per: Manley, H, et al.
Publicat: (2024)

Adherence to the paediatric immunisation schedule in England
per: Bauwens, J, et al.
Publicat: (2021)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
per: Godwin Oligbu, et al.
Publicat: (2019-09-01)

Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in England
per: Manley, H, et al.
Publicat: (2024)

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales
per: Abdelmajid Djennad, et al.
Publicat: (2018-12-01)

Combining models to generate consensus medium-term projections of hospital admissions, occupancy and deaths relating to COVID-19 in England
per: Harrison Manley, et al.
Publicat: (2024-05-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
per: Sleeman, K, et al.
Publicat: (2001)

Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England.
per: Foster, D, et al.
Publicat: (2011)

Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey.
per: McCabe, R, et al.
Publicat: (2024)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
per: Ezra Linley, et al.
Publicat: (2019-01-01)

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule
per: Bauwens, J, et al.
Publicat: (2021)

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
per: Marta Bertran, et al.
Publicat: (2022-08-01)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
per: Ashley Makwana, et al.
Publicat: (2018-10-01)

Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey
per: Ruth McCabe, et al.
Publicat: (2024-06-01)

Estimating age-stratified influenza-associated invasive pneumococcal disease in England: a time-series model based on population surveillance data
per: Chiavenna, C, et al.
Publicat: (2019)

7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?
per: Yoon Hong Choi, et al.
Publicat: (2011-01-01)

Increased Invasive Pneumococcal Disease, North East England, UK
per: Catherine Houseman, et al.
Publicat: (2017-01-01)

Is immunisation child protection?
per: Finn, A, et al.
Publicat: (2011)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
per: Foster, D, et al.
Publicat: (2008)

Genetic immunisation
per: Johnson, T, et al.
Publicat: (2021)

Presentations at the UK National Immunisation Conference
per: Pollard, AJ, et al.
Publicat: (2022)

Immunisation
per: B Farham
Publicat: (2023-04-01)

Pneumococcal carriage and disease in adults in England, 2011–2019: the importance of adults as a reservoir for pneumococcus in communities
per: El Safadi, D, et al.
Publicat: (2024)

Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling
per: De Cao, E, et al.
Publicat: (2014)

The interplay between susceptibility and vaccine effectiveness control the timing and size of an emerging seasonal influenza wave in England
per: van Leeuwen, E, et al.
Publicat: (2023)

The interplay between susceptibility and vaccine effectiveness control the timing and size of an emerging seasonal influenza wave in England
per: E. van Leeuwen, et al.
Publicat: (2023-09-01)

Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
per: Moore, C, et al.
Publicat: (2014)

Schedules for pneumococcal vaccination of preterm infants: an RCT
per: Kent, A, et al.
Publicat: (2016)

Immunisation status in hospitalised infants: reasons for incomplete immunisation
per: Othman, Norlijah, et al.
Publicat: (2005)

Getting it right—the Australian Childhood Immunisation Register and immunisation rates in south‐eastern Sydney
per: Susan J. Botham, et al.
Publicat: (2004-02-01)

Immunisation of adolescents in the UK.
per: Kale, A, et al.
Publicat: (2011)

Views of Zulus and Southern Sothos on immunisation
per: A.J. Lubbe
Publicat: (1984-09-01)

10-minute consultation: MMR immunisation.
per: Harnden, A, et al.
Publicat: (2001)

Paracetamol and infant immunisation
per: Ford, K, et al.
Publicat: (2007)

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
per: Snape, MD, et al.
Publicat: (2006)

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.
per: Heath, P, et al.
Publicat: (1997)

Childhood immunisation: what is the future?
per: Pollard, A
Publicat: (2007)

Childhood immunisation: what is the future?
per: Pollard, A
Publicat: (2007)

Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
per: Fiona McQuaid, et al.
Publicat: (2022-02-01)